Open AccessMultisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy
Author(s) -
Morgan M. Philbin,
Carrigan Parish,
Elizabeth N. Kinnard,
Sarah E. Reed,
Deanna Kerrigan,
María L. Alcaide,
Mardge H. Cohen,
Oluwakemi Sosanya,
Anandi N. Sheth,
Adaora A. Adimora,
Jennifer Cocohoba,
Lakshmi Goparaju,
Elizabeth T. Golub,
Margaret A. Fischl,
Lisa R. Metsch
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002337
Subject(s) - pill , medicine , thematic analysis , clinical trial , family medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , gerontology , viral load , qualitative research , nursing , social science , sociology
Adherence to antiretroviral therapy (ART) is imperative for viral suppression and reducing HIV transmission, but many people living with HIV report difficultly sustaining long-term adherence. Long-acting injectable (LAI) ART has the potential to transform HIV treatment and prevention. However, little LAI ART-related behavioral research has occurred among women, particularly outside of clinical trials.